Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.32 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Threonine SCHEMBL2765872 | 0.89 | SLC7A5 (0.39) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| SCHEMBL1514088 | 0.85 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| SCHEMBL1514108 | 0.85 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| SCHEMBL442281 | 0.85 | SLC7A5 (0.30) | SLC7A5 | |
| Glycine SCHEMBL8005617 | 0.82 | SLC7A5 (0.41) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| Threonine SCHEMBL5073183 | 0.81 | SLC7A5 (0.38) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2702062 | 0.80 | SLC7A5 (0.46) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| Threonine SCHEMBL6856748 | 0.80 | SLC7A5 (0.36) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6038226 | 0.78 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 | |
| SCHEMBL288383 | 0.78 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006170-B2 | Compositions for elastogenesis and connective tissue treatment | HUMAN MATRIX SCIENCES, LLC (US) | 2015-04-14 | — | — | US | disclosed |
| US-8871707-B2 | Elastin producing fibroblast formulations and methods of using the same | HUMAN MATRIX SCIENCES, LLC (US) | 2014-10-28 | — | — | US | disclosed |
| US-20110081322-A1 | ELASTIN PRODUCING FIBROBLAST FORMULATIONS AND METHODS OF USING THE SAME | NULASTIN, INC. | 2011-04-07 | — | — | US | disclosed |
| US-7803522-B2 | Elastin producing fibroblast formulations and methods of using the same | HUMAN MATRIX SCIENCES, LLC (US) | 2010-09-28 | — | — | US | disclosed |
| US-7560430-B2 | To stimulate the endogenous production of Elastin or appear to enhance the elasticity of the skin | HUMAN MATRIX SCIENCES, LLC (US) | 2009-07-14 | — | — | US | disclosed |
| US-20080050346-A1 | Elastin producing fibroblast formulations and methods of using the same | NULASTIN, INC. | 2008-02-28 | — | — | US | disclosed |